Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Zydus Overhauling Vaccine Site Amid WHO Notice

This article was originally published in PharmAsia News

Executive Summary

Zydus Cadila appears to be implementing a major corrective and preventive action (CAPA) plan at its Moraiya site in India pertaining to its rabies vaccine, following a damning notice of concern from the WHO.



Related Companies